Miyamoto T, Maeda T, Onishi S, Yamamoto Y
First Department of Internal Medicine, Kochi Medical School, Japan.
J Hepatol. 1995 Apr;22(4):423-30. doi: 10.1016/0168-8278(95)80105-7.
BACKGROUND/AIMS: Cellular immune responses against biliary epithelial cells are important in understanding the pathogenesis of primary biliary cirrhosis. We previously reported a biliary antigen B1 which stimulated peripheral T lymphocytes of primary biliary cirrhosis as a possible, non-mitochondrial target of biliary epithelial cells. Further characterization of B1 was performed.
To confirm localization of B1 in biliary epithelial cells, a mouse monoclonal antibody was raised against B1. As B1 could be separated into two main components by SDS-PAGE under reducing condition, these components were individually cut out from Western blots and converted into antigen-bearing particles for a proliferation assay to detect the antigenic component responsible for stimulating lymphocytes. The relation of this proliferation to HLA DR antigens was also analyzed.
Immunohistochemically, B1 was shown to be specifically expressed on biliary epithelial cells of human liver tissue. Of two components from B1 under reducing condition, prominent proliferation against B1-p28, a 28 kD component of B1 was detected in primary biliary cirrhosis. The reactivities were significantly higher than chronic liver diseases (p < 0.001) or normal controls (p < 0.001). Furthermore, high responders to B1-p28 were observed frequently in primary biliary cirrhosis patients with HLA DR8 (p < 0.02), which was susceptible to the development of primary biliary cirrhosis.
These data suggest B1-p28 expressed on biliary epithelial cells is a candidate for the target antigen of primary biliary cirrhosis in addition to mitochondrial autoantigens. Further characterization of B1-p28 may provide new insight into the autoimmune mechanisms of primary biliary cirrhosis.
背景/目的:针对胆管上皮细胞的细胞免疫反应对于理解原发性胆汁性肝硬化的发病机制至关重要。我们之前报道了一种胆管抗原B1,它可刺激原发性胆汁性肝硬化患者的外周血T淋巴细胞,可能是胆管上皮细胞的一种非线粒体靶点。本研究对B1进行了进一步的特性分析。
为了确定B1在胆管上皮细胞中的定位,制备了针对B1的小鼠单克隆抗体。由于在还原条件下,B1可通过SDS-PAGE分离为两个主要成分,将这些成分分别从Western印迹中切下,并转化为携带抗原的颗粒用于增殖试验,以检测负责刺激淋巴细胞的抗原成分。同时分析了这种增殖与HLA DR抗原的关系。
免疫组织化学显示,B1特异性表达于人肝组织的胆管上皮细胞上。在还原条件下,B1的两个成分中,原发性胆汁性肝硬化患者对B1-p28(B1的一个28 kD成分)有显著的增殖反应。其反应性显著高于慢性肝病患者(p < 0.001)或正常对照(p < 0.001)。此外,在携带HLA DR8的原发性胆汁性肝硬化患者中,对B1-p28高反应者较为常见(p < 0.02),而HLA DR8与原发性胆汁性肝硬化的发生易感性相关。
这些数据表明,胆管上皮细胞上表达的B1-p28除了线粒体自身抗原外,可能是原发性胆汁性肝硬化的靶抗原候选物。对B1-p28的进一步特性分析可能为原发性胆汁性肝硬化的自身免疫机制提供新的见解。